Sarilumab use in severe SARS-CoV-2 pneumonia-Reference-Cited by-同舟云学术

Sarilumab use in severe SARS-CoV-2 pneumonia

Published:2020-10 Issue: Volume:27 Page:100553
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Gremese Elisa,Cingolani Antonella,Bosello Silvia Laura,Alivernini Stefano,Tolusso Barbara,Perniola Simone,Landi Francesco,Pompili Maurizio,Murri Rita,Santoliquido Angelo,Garcovich Matteo,Sali Michela,De Pascale Gennaro,Gabrielli Maurizio,Biscetti Federico^ORCID,Montalto Massimo,Tosoni Alberto,Gambassi Giovanni,Rapaccini Gian Ludovico,Iaconelli Amerigo,Zileri Del Verme Lorenzo,Petricca Luca,Fedele Anna Laura,Lizzio Marco Maria,Tamburrini Enrica,Natalello Gerlando,Gigante Laura,Bruno Dario,Verardi Lucrezia,Taddei Eleonora,Calabrese Angelo,Lombardi Francesco,Bernabei Roberto,Cauda Roberto,Franceschi Francesco,Landolfi Raffaele,Richeldi Luca,Sanguinetti Maurizio,Fantoni Massimo,Antonelli Massimo,Gasbarrini Antonio

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. A novel Coronavirus from patients with pneumonia in China, 2019;Zhu;N Engl J Med,2020

2. Covid 19: preparedness, decentralization and dehunt for patient zero;Carinci;BMJ,2020

3. Italian Ministry of Health (www.salute.gov.it)

4. Clinical features of patients infected with 2019 novel coronavirus in Wuhan China;Huang;Lancet,2020

5. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus –infected pneumonia in Wuhan China;Wuang;JAMA,2020

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19;Journal of Infection;2024-10

2. Efficacy of sarilumab and dexamethasone co-administration for lowering multiple blood biomarkers in the treatment of cytokine release syndrome in hospitalized covid-19 patients;Journal of the Pakistan Medical Association;2024-06-28

3. Sarilumab is not Inferior to Tocilizumab in the Treatment of Cytokine Release Syndrome in COVID-19;Russian Journal of Gastroenterology, Hepatology, Coloproctology;2023-12-02

4. COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery;Genes & Diseases;2023-07

5. Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis;Tomography;2023-05-11